z-logo
open-access-imgOpen Access
Effect of Greater cardamom (Amomum subulatum Roxb.) on blood lipids, fibrinolysis and total antioxidant status in patients with ischemic heart disease
Author(s) -
Surendra Kumar Verma,
Vartika Jain,
Dharam Raj Singh
Publication year - 2012
Publication title -
asian pacific journal of tropical disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.208
H-Index - 33
ISSN - 2222-1808
DOI - 10.1016/s2222-1808(12)60255-2
Subject(s) - fibrinolysis , placebo , medicine , antioxidant , lipid profile , blood lipids , cholesterol , traditional medicine , biology , biochemistry , pathology , alternative medicine
Objective: Greater cardamom (Amomum subulatum Roxb.) fruit powder (seeds with pericarp) was\udevaluated for its effect on some of the cardiovascular risk factors in patients with ischemic heart\uddisease. Methods: Thirty male individuals (50-70 years) with ischemic heart disease (old MI>6\udmonths) were selected for the study and divided into two groups of fifteen each. Group I (Treated)\udreceived 3 g cardamom powder in two divided doses while Group II (Placebo) received matched\udplacebo capsules for 12 weeks. Blood samples were collected initially and at 6 and 12 weeks for\udanalysis of lipid profile, fibrinolytic activity and total antioxidant status. Results: Administration\udof Greater cardamom significantly (P<0.001 ) reduced atherogenic lipids without significant\udalteration in HDL-cholesterol. Plasma fibrinolytic activity and serum total antioxidant status were\udalso enhanced significantly (P<0.05) at the end of the study. The placebo group however did not\udshow significant alteration in any of these parameters. It was tolerated well without any untoward\udeffects. Conclusions: Dietary supplementation of Greater cardamom favorably modifies lipid\udprofile and significantly enhances fibrinolytic activity and total antioxidant status in patients with\udischemic heart disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here